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Introduction
Hyaline cartilage is an important intra-articular structure 
that is prone to damage by trauma or degeneration. 
Damaged cartilage is one of the key tissues in the disease 
process that is understood as osteoarthritis (OA), a 
multi-tissue disease leading eventually to joint failure [1]. 
For decades, direct imaging of cartilage was not possible 
and investigators relied instead on indirect methods 
using conventional radiography. Loss of joint space width 
(JSW), or joint space narrowing (JSN), is considered a 
surrogate marker for cartilage damage [2]. In contrast, 
magnetic resonance imaging (MRI) allows direct visuali-
za  tion of cartilage, and technologic advances have led to 
sophisticated tools such as high-resolution morphologic 
imaging and compositional or biochemical assessment 
[3].
In this review, we will ﬁ  rst describe the current role of 
conventional radiography for cartilage assessment in OA 
and then discuss the current and future roles of MRI for 
the evaluation of cartilage pathology in OA. We will 
explain the strengths and limitations of both imaging 
modalities on the basis of available evidence from the 
literature and elucidate why today MRI should be 
considered the imaging modality of choice for cartilage 
assessment in the context of OA of the knee joint.
Imaging of cartilage by radiography
Radiographs are used in clinical practice to establish the 
diagnosis of OA and to monitor the progression of the 
disease. Radiography can clearly visualize bony features, 
such as marginal osteophytes, subchondral cysts, and 
sclerosis, that are characteristic features of OA, but direct 
visualization of cartilage is not possible. Instead, radio-
graphy allows an indirect estimate of cartilage thickness 
and meniscal integrity by assessment of JSW in the 
patello  femoral and tibiofemoral joints.
At present, radiographic diagnosis of knee OA is based 
on the Kellgren-Lawrence (KL) grading system, a semi-
quantitative composite score that is based on two radio-
graphic features: the presence of osteophytes and JSN [4]. 
Radiographic knee OA is deﬁ  ned as KL grade 2 or above: 
that is, the presence of a deﬁ  nite marginal osteophyte 
(KL grade 2), the presence of JSN (KL grade 3), or bone-
on-bone contact (KL grade 4) [5]. Once a knee exhibits 
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Imaging of cartilage has traditionally been achieved 
indirectly with conventional radiography. Loss of joint 
space width, or ‘joint space narrowing’, is considered 
a surrogate marker for cartilage thinning. However, 
radiography is severely limited by its inability to visualize 
cartilage, the diffi   culty of ascertaining the optimum 
and reproducible positioning of the joint in serial 
assessments, and the diffi   culty of grading joint space 
narrowing visually. With the availability of advanced 
magnetic resonance imaging (MRI) scanners, new 
pulse sequences, and imaging techniques, direct 
visualization of cartilage has become possible. MRI 
enables visualization not only of cartilage but also of 
other important features of osteoarthritis simultaneously. 
‘Pre-radiographic’ cartilage changes depicted by 
MRI can be measured reliably by a semiquantitative 
or quantitative approach. MRI enables accurate 
measurement of longitudinal changes in quantitative 
cartilage morphology in knee osteoarthritis. Moreover, 
compositional MRI allows imaging of ‘pre-morphologic’ 
changes (that is, visualization of subtle intrasubstance 
matrix changes before any obvious morphologic 
alterations occur). Detection of joint space narrowing 
on radiography seems outdated now that it is possible 
to directly visualize morphologic and pre-morphologic 
changes of cartilage by using conventional as well as 
complex MRI techniques.
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© 2011 BioMed Central LtdJSN in either the medial or lateral tibiofemoral compart-
ment, the knee is classiﬁ  ed as osteoarthritic despite the 
absence of obvious osteophytes. Assessment of knee OA 
severity relies mainly on JSN and subchondral bone 
lesions. Increased JSN is the most commonly used 
criterion for deﬁ  ning longitudinal OA progression, and 
the complete loss of JSW, characterized by bone-on-bone 
contact on the weight-bearing anteroposterior (AP) 
radiograph, is one of the factors in the decision for joint 
replacement [2]. In contrast to the KL scheme, the 
Osteoarthritis Research Society International (OARSI) 
atlas classiﬁ     cation scores tibiofemoral JSN and osteo-
phytes separately in each compartment of the knee [6] by 
using a 4-point scale (0-3).
Radiography is available virtually everywhere and its 
cost is much lower than that of MRI. Imaging time is 
short, and there is little discomfort for the patient. 
Automated software that delineates the femoral and tibial 
margins of the joint and that calculates JSW at ﬁ  xed 
locations has been developed, and the relative responsive-
ness of JSW measurements from digital knee radio  graphic 
images has been shown to be comparable to cartilage 
morphometry measures derived from MRI in detecting 
OA progression [7]. At present, radiographically detected 
JSN is the only structural endpoint accepted by the 
regulatory bodies in the US (US Food and Drug Adminis-
tration, or FDA) and Europe (European Medicines 
Agency) to prove eﬃ     cacy of disease-modifying osteo-
arthritis drugs (DMOADs) targeting OA in phase III 
clinical trials [5]. According to the recently published 
summary and recommendations of the OARSI FDA OA 
Assessment of Structural Change Working Group, 
radiographic JSW is still a recommended option for trials 
of structure modiﬁ  cation although the construct repre-
sents a number of pathologies and trial duration may be 
long [8].
Limitations of radiography
Th  e lack of reproducibility of radiographic joint space 
measurements in longitudinal assessment is one of the 
main shortcomings of radiography, especially for the 
extended-knee radiograph (that is, a bilateral weight-
bearing AP view of both knees in full extension) [5]. 
Changes in knee pain between examinations can intro-
duce systematic measurement error for radiographs in 
full extension [2]. Mazzuca and colleagues [9] detected 
signiﬁ   cant increases in tibiofemoral JSW in extended-
knee radiographs taken 7 to 14 days apart of OA subjects 
who had experienced relief of an induced ﬂ  are of knee 
OA pain. Notable diﬀ  erences in JSW may be demon-
strated depending on the angulation of the knee 
(Figure 1). Th   us, the lack of reproducibility of positioning 
in longitudinal studies and large multicenter trials 
remains a major drawback to the use of radiography.
To overcome this problem, various protocols have been 
proposed to enable standardized radiographic assessment 
of the knee [2]. Of those, the ﬁ  xed ﬂ  exion view with the 
use of a positioning frame (for example, SynaFlexer™; 
CCBR-SYNARC, Newark, CA, USA) [10] is the most 
widely used protocol in ongoing large-scale multicenter 
OA studies, such as the Osteoarthritis Initiative (OAI) 
and the Multicenter Osteoarthritis Study (MOST). Other 
protocols use ﬂ   uoroscopy to conﬁ  rm  satis  factory 
anatomical positioning of the medial tibial plateau prior 
to acquisition of the radiograph [11,12].
Such measures may alleviate the problems associated 
with positioning, but even if the image acquisition method 
is optimized, interpreting JSN may still be problem  atic. 
Based on data from the OAI, a recent study by Guermazi 
and colleagues [13] showed marked diﬀ  erences  in 
thresholds for scoring of JSN between expert readers. In 
light of these ﬁ   ndings, research studies using radio-
graphic semiquantitative grading of OA should rely on 
centralized adjudicated reading for all grading in order to 
minimize variability.
Th   e inability of radiography to directly visualize 
cartilage and many other OA features is the insur  mount-
able shortcoming of this imaging modality (Figure  2). 
Recently, Amin and colleagues [14] examined the 
relationship between progression of JSN on radiographic 
images and cartilage loss on MRI. While their results 
provided longitudinal evidence that radiographic 
progression of JSN is corre  lated with cartilage loss 
assessed on MRI, the authors concluded that if 
radiography were used alone, a sub  stantial proportion of 
knees with cartilage loss would be missed [14]. In 
longitudinal studies, radiographic pro  gres  sion of JSN is 
neither a sensitive [14] (Figures 3 and 4) nor a speciﬁ  c [1] 
(Figure 5) measure of OA disease progression when 
compared with MRI ﬁ  ndings.
It was previously believed that JSN and its changes 
reﬂ   ect only articular cartilage thinning, but several 
studies have shown that alterations in the meniscus, such 
as meniscal extrusion or subluxation, also contribute to 
JSN [1,15,16]. A more recent study, by Hunter and 
colleagues [1], compared MRI and weight-bearing postero-
anterior radiographs to explore the relative contribution 
of several morphologic features, including cartilage, 
meniscal damage, and position, to the radiographically 
detected JSN. Th  e authors found that a substantial 
proportion of the explained variance in JSN was due to 
meniscal position and degeneration, and a substantial 
proportion of change in JSN resulted from change in 
meniscal position.
Lastly, one should note that patients usually have 
medial knee OA and the regular use of JSW measure-
ments is performed in the medial compartment. 
However, the lateral joint space may become widened as 
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of joint space, articular cartilage in the lateral compart-
ment may be normal or abnormal, but even if there is 
cartilage thinning, it is very diﬃ     cult to assess by 
radiography alone [17].
Imaging of cartilage by magnetic resonance 
imaging
An important advantage of MRI over radiography is the 
ability of the former to visualize cartilage and other joint 
tissues directly. MRI is a powerful non-invasive tool for 
detecting cartilage damage and for monitoring the eﬀ  ects 
of conservative and surgical therapy [3]. Other charac-
teristic OA features, such as bone marrow lesions, 
meniscal lesions, and synovitis, can be visualized and 
assessed simultaneously (Figure 2), enabling study of the 
potential OA risk factors and mechanisms of the OA 
disease process [18,19]. MRI techniques used for the 
assess  ment of cartilage can be divided broadly into two 
categories: morphologic and compositional evaluation 
[3].
Morphologic assessment
MRI techniques for morphologic assessment of knee 
articular cartilage provide accurate information about 
focal or diﬀ  use partial- or full-thickness cartilage loss [3]. 
In clinical research, especially in knee OA studies, 
morphologic assessment of cartilage with MRI is per-
formed by using semiquantitative scoring methods, such 
as the Whole Organ Magnetic Resonance Imaging Score 
(WORMS) [20], the Boston Leeds Osteoarthritis Knee 
Score (BLOKS) [21], and the Knee Osteoarthritis Scoring 
System (KOSS) [22]. For example, in WORMS, cartilage 
signal and morphology are scored on a point scale of 0 to 
6 (that is, 0, 1, 2, 2.5, 3, 4, 5, and 6, where 0 is normal and 
6 is diﬀ   use full-thickness loss) in 14 articular surface 
regions of the knee joint. Th  e other methods employ 
similar semi  quantitative approaches, and details can be 
found in the original publications. Excellent reliability 
data have been published for all three scoring systems 
[23]. Additionally, a new scoring system (called Magnetic 
Resonance Imaging Osteoarthritis Knee Score, or 
MOAKS) has been developed to maximize the advantages 
Figure 1. Radiographs at baseline and 2-year follow-up of a 61-year-old woman with osteoarthritis. At two time points, radiographs were 
taken with 5°, 10°, and 15° angulation of the knee. (a) Anteroposterior (AP) radiograph taken at 5° angulation shows medial joint space narrowing 
(OARSI grade 2 and Kellgren-Lawrence grade 3). (b) However, AP radiograph taken at 10° angulation shows OARSI grade 3 joint space narrowing 
(Kellgren-Lawrence grade 4). (c) Similarly, at follow-up, AP radiograph taken at 5° angulation shows OARSI grade 2 joint space narrowing (Kellgren-
Lawrence grade 3) whereas that taken at 15° angulation (d) shows OARSI grade 3 joint space narrowing (Kellgren-Lawrence grade 4). If images 
(b) and (c) are compared longitudinally, one observes a paradoxical ‘joint space widening’. This example highlights the importance of technique to 
ascertain the reproducibility of the same angulation of the knee in longitudinal studies. OARSI, Osteoarthritis Research Society International.
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[24].
Th   ese semiquantitative methods evaluate the morpho-
logic characteristics of articular cartilage in conjunction 
with those of other intra- and periarticular structures (for 
example, subchondral bone, menisci, osteophytes, and 
synovium) in order to establish risk factors for symptoms 
and structural progression of disease. Th   ese features are 
also used as outcome measures, and cartilage is the most 
commonly applied [23]. Using the WORMS method, 
Roemer and colleagues [25] showed that, in participants 
with no or only minimal baseline cartilage damage, a high 
body mass index, meniscal damage, synovitis, or eﬀ  usion 
or the presence of any severe baseline MRI-depicted 
lesions is strongly associated with an increased risk of 
rapid cartilage loss.
Crema and colleagues [3] recently summarized details 
of currently available MRI techniques for morphologic 
assessment (that is, conventional spin-echo (SE) sequences 
and gradient-recalled echo (GRE) sequences, fast spin 
echo (FSE) sequences, and more advanced three-
dimensional (3D) SE and GRE sequences). Each 
technique has its strengths and limitations, and the 
physician or researcher must consider them carefully 
when selecting appropriate techniques for a particular 
study.
Quantitative analysis of cartilage morphology exploits 
the 3D nature of MRI data sets to assess tissue dimen-
sions, such as volume and thickness, or signal as con-
tinuous variables. A recent meta-analysis demonstrated 
that MRI can measure change in quantitative cartilage 
morphometry reliably and with good responsiveness 
[26]. Multiple MRI-based quantitative cartilage measures 
(for example, volume, surface area, and percentage of 
total area of bone not covered by cartilage) can be used, 
but most of these are strongly related, and it appears that 
some may be redundant or contain minimal additional 
information. Buck and colleagues [27] performed a study 
to identify an eﬃ   cient subset of core measures which 
comprises a comprehensive description of cartilage mor-
phology and its longitudinal changes in healthy and 
diseased cartilage. Th   e study showed that three measures 
(that is, mean cartilage thickness over the total area of 
the subchondral bone, total subchondral bone area, and 
percentage of denuded area of the subchondral bone) 
explain over 90% of the cross-sectional and longitudinal 
variation in a larger set of common cartilage morphology 
measures in knees with or without OA. Focusing on this 
eﬃ   cient subset of knee cartilage morphology measures 
should be encouraged in future studies.
A  nother strategy for a more eﬃ   cient measurement of 
cartilage thickness has been proposed by Buck and 
colleagues [28]. Th   e sensitivity to change of quantitative 
analysis of cartilage in knee OA by using MRI is com-
promised by the spatial h  eterogeneity of cartilage loss. 
Th  e authors hypothesized that determining the magni-
tude of thickness change independently of anato  mic 
location provided improved discrimination between 
healthy subjects and OA participants longitudinally. Th  e 
study showed that this ‘ordered values approach’ is 
sensitive to cartilage thinning in KL grade 3 and cartilage 
thickening in KL grade 2 versus KL grade 0 participants. 
Figure 2. Comparison of an anteroposterior radiograph and a coronal magnetic resonance image of the knee. (a) Anteroposterior 
radiograph of the left knee demonstrates marginal osteophytes of the medial and lateral femur and tibia (arrows). Joint space width appears 
normal in the lateral tibiofemoral compartment, but there is mild to moderate medial tibiofemoral joint space narrowing. No other obvious bony 
abnormalities are seen. (b) Coronal fat-suppressed proton density-weighted magnetic resonance imaging performed on the same day reveals a 
subchondral bone marrow lesion (thin white arrow) at the medial tibial plateau subjacent to a focal full-thickness cartilage defect. Multiple partial-
thickness defects of the medial femoral condyle cartilage (white arrowheads) are also noted. Notably, focal full-thickness cartilage defects (gray 
arrowhead) are more extensive at the lateral femoral condyle and subchondral bone (black arrowheads) is almost completely denuded at the 
lateral tibial condyle, despite radiographically normal appearance of the lateral tibiofemoral joint space width. Most of the joint space narrowing of 
the medial tibiofemoral joint is secondary to a partially macerated and extruded medial meniscus (thick white arrow). Additionally, there is attrition 
of the medial and lateral tibial plateaus and marginal osteophytosis. This example demonstrates why radiography should no longer be considered a 
surrogate outcome measure for longitudinal assessment of cartilage in knee osteoarthritis.
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that an ‘extended ordered values approach’ shows higher 
sensitivity to diﬀ  erences in longitudinal rates of cartilage 
loss in knees with and without baseline JSN than 
anatomical subregions and radiography. Because they 
circumvent the challenges of a priori selection of 
particular regions in clinical trials, these novel methods 
may become useful tools in DMOAD trials [29].
Q  uantitative MRI has been used in clinical trials 
assessing the eﬃ   cacy of pharmacologic therapy of OA. In 
a comparison of users of cyclooxygenase-2 inhibitors 
with users of conventional non-steroidal anti-inﬂ  am  ma-
tory drugs, the latter group was reported to have higher 
knee cartilage volume loss [30]. Quantitative MRI has 
also been used in studies attempting to identify bio-
markers for prediction of OA disease progression. Higher 
bone remodeling was associated with reduced cartilage 
loss [31], and low levels of cartilage biomarkers at 
baseline were associated with a signiﬁ  cantly reduced rate 
of medial cartilage volume loss [32]. Higher baseline 
values of interleukin-6, C-reactive protein, and cartilage 
oligomeric matrix protein were predictive of greater risk 
of cartilage volume loss [33], but over time a reduction in 
matrix metalloproteinase (MMP)-1 and MMP-3 levels 
correlated best with reduced cartilage volume loss and 
the eﬀ  ect of DMOAD treatment.
Compositional assessment
Hyaline articular cartilage is composed of a ﬂ  uid-ﬁ  lled 
macromolecular network that supports mechanical 
loads. Th  is macromolecular network consists mainly of 
collagen and proteoglycans. Collagen is the most abun-
dant macromolecule, and aggrecan, a large aggregating 
proteoglycan, is the second most abundant. In normal 
joints, the collagen network acts as the structural 
framework for tissue, providing the main source of its 
tensile and shear strength. Glycosaminoglycans are 
covalently attached as side chains to the proteoglycan 
molecule and exhibit abundant negatively charged 
carboxyl and sulfate groups. Glycosaminoglycans provide 
the cartilage considerable compressive strength. Because 
proteoglycans have a substantial net negative ﬁ  xed 
Figure 3. Example of non-sensitivity of radiography. (a) Baseline coronal intermediate-weighted magnetic resonance imaging shows 
hyperintensity in the weight-bearing portion of the lateral tibial plateau but no defi  nite cartilage defect. (b) At 24-month follow-up, an incident 
focal full-thickness defect has developed in the corresponding area of the lateral tibial plateau (arrows). (c) Baseline anteroposterior radiograph 
does not show any joint space narrowing in the lateral tibiofemoral joint. (d) No change to baseline is observed at 24-month follow-up.
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gadolinium-based contrast agents for MRI (for example, 
gadolinium diethylene triamine pentaacetic acid (Gd-
DTPA)2−) are distributed in relation to the proteoglycan 
concentration in cartilage, with Na+ lower in concen  tra-
tion and Gd-DTPA2− higher in concentration in glyco-
samino  glycan-depleted cartilage relative to normal tissue. 
Because collagen- and proteoglycan-associated glyco-
saminoglycans are important to the functional and 
structural integrity of cartilage, compositional MRI of 
cartilage is focused on collagen and glycosaminoglycan 
content [34]. MRI techniques for assessing the compo-
sitional characteristics of articular cartilage in the knee 
include T2 mapping, delayed gadolinium-enhanced mag-
netic resonance imaging of cartilage (dGEMRIC), T1 rho 
imaging, sodium imaging, and diﬀ  usion-weighted 
imaging (DWI).
T2 mapping is perhaps the most studied parameter for 
molecular imaging of cartilage. T2 is a reﬂ  ection of the 
interactions between water molecules and surrounding 
macromolecules and is aﬀ  ected by many physiologic and 
pathophysiologic processes related to the state of 
cartilage. Focal increase in T2 relaxation time has been 
asso  ciated with cartilage matrix damage, particularly 
with loss of collagen integrity and an increase in water 
content [35-37]. T2 mapping techniques do not use con-
trast material, have been shown to be clinically useful, 
and are well validated and robust [3]. T2 maps may be 
used to monitor the eﬀ  ectiveness of cartilage repair over 
time [38]. T2 mapping can be implemented relatively 
easily since software for generating color T2 maps is now 
available in commercial packages [3].
T1 rho, like T2, is sensitive to inter  actions of water with 
macromolecules. T1 rho has been shown to correlate 
with the proteoglycan concentration in cartilage [39]. A 
recent study demonstrated that changes of T1 rho with 
loading may be related to cartilage biomechanical 
properties (that is, elasticity) and may be a valuable tool 
for identifying early cartilage disease [40].
Th   e delayed gadolinium-enhanced magnetic resonance 
imaging of cartilage (dGEMRIC) technique is based on 
the fact that glycosaminoglycans contain negatively 
charged side chains, which lead to an inverse distribution 
of negatively charged contrast agent molecules (such as 
gadolinium) with respect to glycosaminoglycans concen-
tra  tion. As the concentration of Gd-DTPA2− molecules 
can be approximated by measuring T1, T1 mapping of 
cartilage after intravenous administration of Gd-DTPA2− 
allows a quantitative assessment of glycosaminoglycan 
content [3,34]. Th   e T1 measurement after penetration of 
Figure 4. Example of non-sensitivity of radiography. (a) Baseline sagittal intermediate-weighted fat-suppressed image shows normal articular 
cartilage coverage in the medial femur and tibia. (b) At 24-month follow-up, there is circumscribed thinning of cartilage in the posterior medial 
femur (arrows). (c) Baseline radiograph does not show any abnormalities in regard to joint space width or any defi  nite osteophytes at the medial 
tibia (no arrow). (d) At 24-month follow-up, no change is observed in comparison with the baseline image.
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of cartilage with a lower dGEMRIC index are commonly 
observed in joints in which radiographic ﬁ  ndings  are 
indicative of OA [41]. Th  e dGEMRIC index has been 
validated against histo  logic and biochemical measure-
ments of glycosamino  glycan content in clinical studies 
[42]. dGEMRIC has potential as a non-invasive technique 
for monitoring the glycosaminoglycan content of 
cartilage after repair by various techniques [43] 
(Figure 6). It has also shown the ability to demonstrate 
changes in morphologically intact cartilage that may be 
predictive of progression to OA [44]. A recent pilot 
randomized controlled trial showed that the dGEMRIC 
technique may be able to detect changes in proteoglycan 
content in knee cartilage among individuals taking 
collagen hydrolysate after 24 weeks [45]. Drawbacks of 
the dGEMRIC technique are the double dose of MRI 
contrast agent that is needed and the delay between 
intravenous contrast administration and MRI exami-
nation to allow complete penetration of the contrast 
agent into the cartilage.
Sodium is a naturally abundant positively charged ion 
that will distribute itself in cartilage in proportion to the 
concentration of negatively charged glycosaminoglycan 
molecules. Sodium MRI has demonstrated promising 
results in the compositional assessment of articular 
cartilage. It can depict regions of proteoglycan depletion, 
which exhibit lower signal intensity than do areas of 
normal cartilage [46-48]. Th  us, sodium MRI may be 
useful for diﬀ  erentiating between early-stage degenerated 
cartilage and normal cartilage [48]. Although sodium 
MRI has high speciﬁ   city and does not require any 
exogenous contrast agent, it does require special hard-
ware capabilities (multinuclear), specialized radio  fre-
quency coils (transmit/receive), and likely 3D ultrashort 
TE sequences. Th   ese challenges currently limit the use of 
sodium MRI in a clinical setting.
Lastly, DWI of cartilage is based on the motion of water 
molecules within cartilage. Th   e magnitude and direction 
of local tissue diﬀ   usivity are related to the macro-
molecular environment of bulk water diﬀ  usion.  Th  e 
diﬀ  usion of water in articular cartilage reﬂ  ects the bio-
chemical structure and architecture of the tissue. Th  e 
apparent diﬀ  usion coeﬃ   cient (ADC) is low at long diﬀ  u-
sion times in healthy cartilage because the diﬀ  usion of 
water molecules is restricted by cartilage components. 
Figure 5. Example of non-specifi  city of radiography. (a) Baseline sagittal intermediate-weighted fat-suppressed image shows discrete superfi  cial 
cartilage loss at the central part of the medial femur (arrows). (b) No progression is seen at 24-month follow-up (arrowheads). (c) Radiographic joint 
space narrowing is depicted at baseline (arrowheads). (d) Further decrease in joint space width is shown at 24-month follow-up (arrows) and was 
due to meniscal extrusion (not shown).
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enhanced water mobility, which increases the ADC 
values of cartilage [49]. A recent study of DWI in the 
assessment of cartilage repair such as autologous chon-
dro cyte  implantation  in vivo reported good sensitivity for 
tracking changes in the diﬀ  usion behavior of implants 
over time [50]. Th   e last two techniques (that is, sodium 
imaging and DWI) are still in their infancy; to our 
knowledge, no large clinical studies using either tech-
nique in patients with knee OA or knee cartilage repair 
have been published. However, the ﬁ  eld of compositional 
MRI seems to have great potential for increasing our 
understanding of OA and for the development of disease-
modifying treatments.
Performance of magnetic resonance imaging
A recent systematic review by Hunter and colleagues [51] 
revealed that MRI as an outcome measure in OA pro-
vided strong support for both its concurrent and 
predictive validity. MRI cartilage ﬁ  ndings were associated 
with CT arthrographic, histologic, and arthroscopic ﬁ  nd-
ings, but the relation of cartilage volume and thickness 
and compositional measures to the presence of radio-
graphic OA was inconsistent [51]. Th  e litera  ture review 
also demonstrated that cartilage pathology can be measured 
reliably and with good responsive  ness by using a semi-
quantitative or quanti  tative technique [26]. Quanti  tative 
cartilage volume change and presence of cartilage defects 
are potential predictors of total knee replacement [51].
Limitations of magnetic resonance imaging
It is critically important to acquire MRI by using appro-
priate pulse sequences tailored to the speciﬁ  c purpose of 
cartilage assessment. For example, for evaluation of focal 
cartilage defects, ﬂ   uid-sensitive sequences such as fat 
suppression intermediate-weighted, proton density-
weighted, or T2-weighted FSE sequences should be used 
[52-54]. In contrast, GRE sequences such as 3D spoiled 
gradient echo at a steady state (SPGR), fast low angle shot 
(FLASH), 3-point Dixon, and double echo steady state 
(DESS) are well suited for quantitative (volumetric) 
analysis of cartilage [55,56]. Use of inappropriate pulse 
sequences will inevitably invalidate the results of a study 
[57]. Expert musculoskeletal radiologists who can ensure 
the use of adequate imaging protocol may be available in 
only a limited number of institutions. MRI assessment, 
whether a simple visual inspection or a semiquantitative 
or quantitative assessment, is a time-consuming task and 
needs to be performed by trained readers. Centralized 
reading of MRI by expert readers seems to be essential to 
maintain standardized assessment. Some of the tech-
niques may be vendor-speciﬁ  c, and sophisticated MRI 
analyses (such as volumetric segmentations, dGEMRIC, 
and sodium MRI) require specialized software and can 
be done only at selected institutions.
Additional limitations of MRI include (a) diﬃ   culties 
with repositioning in MRI (for example, in the 
evaluation of knee structures by semiquantitative 
scoring and when using dGEMRIC in two dimensions 
longitudinally), (b) challenges of having obese patients 
who might be too obese to ﬁ   t the coil (resulting in 
decreased signal-to-noise ratio), and (c) the fact that 
diﬀ  erent hospitals are equipped with MRI systems from 
various vendors and the use of the identical pulse 
sequences across all sites may not be possible in 
multicenter MRI studies.
Figure 6. dGEMRIC images of knees in an individual without evidence of radiographic osteoarthritis (Kellgren-Lawrence grade 0). 
(a) Before, (b) 3 months after, and (c) 1 year after meniscal repair surgery. The color scale shows values increasing from lower values (red-yellow 
range) to mid-high values (yellow-green range) over this time period. These images demonstrate the potential to show variations in cartilage 
molecular status even in regions of morphologically intact tissue and, as in this case, potentially monitor cartilage repair when relieved of trauma 
or with an intervention designed to improve the biomechanical status of the joint. dGEMRIC, delayed gadolinium-enhanced magnetic resonance 
imaging of cartilage.
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Radiography is severely limited by its inability to directly 
visualize cartilage, the diﬃ   culty of ascertaining the opti-
mum and reproducible positioning of the joint in serial 
assessments, and the diﬃ   culty of grading JSN by visual 
evaluation. MRI enables visualization of not only 
cartilage but also other important features of OA simul-
taneously. Strengths and limitations of radiography and 
MRI are summarized in Table 1. ‘Pre-radiographic’ carti-
lage changes depicted by MRI can be measured reliably 
by using a semiquantitative or quantitative approach. 
MRI enables accurate measurement of longitudinal 
change in quantitative cartilage morphology in knee OA. 
Moreover, compositional MRI allows imag  ing of ‘pre-
morphologic’ changes (that is, visualization of subtle 
intrasubstance matrix changes before any obvious 
morphologic alterations occur). Our research focus has 
shifted from detection of JSN on radiography to visuali-
zation of morphologic and pre-morphologic changes of 
cartilage by using conventional as well as sophisticated 
MRI techniques. To take full advantage of these new 
research tools, consensus-driven MRI-based deﬁ  nitions 
of OA diagnosis and grading of severity need to be 
established and validated, and inclusion of MRI in a new 
regulatory guidance statement for DMOAD clinical trials 
should follow promptly.
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